10976648|t|Gene polymorphism affecting alpha1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk.
10976648|a|Plasma levels of alpha1-antichymotrypsin (ACT) and interleukin-1beta (IL-1beta) were increased in patients with probable Alzheimer's disease (AD). A common polymorphism within ACT and IL-1beta genes affected plasma levels of ACT or IL-1beta, and AD patients with the ACT T,T or IL-1beta T,T genotype showed the highest levels of plasma ACT or IL-1beta, respectively. The concomitant presence of the ACT T,T and IL-1beta T,T genotypes increased the risk of AD (odds ratio: 5.606, confidence interval: 1.654-18.996) and decreased the age at onset of the disease.
10976648	28	51	alpha1-antichymotrypsin	Gene	12
10976648	56	69	interleukin-1	Gene	3552
10976648	94	113	Alzheimer's disease	Disease	MESH:D000544
10976648	137	160	alpha1-antichymotrypsin	Gene	12
10976648	171	188	interleukin-1beta	Gene	3553
10976648	190	198	IL-1beta	Gene	3553
10976648	218	226	patients	Species	9606
10976648	241	260	Alzheimer's disease	Disease	MESH:D000544
10976648	262	264	AD	Disease	MESH:D000544
10976648	304	312	IL-1beta	Gene	3553
10976648	352	360	IL-1beta	Gene	3553
10976648	366	368	AD	Disease	MESH:D000544
10976648	369	377	patients	Species	9606
10976648	398	406	IL-1beta	Gene	3553
10976648	463	471	IL-1beta	Gene	3553
10976648	531	539	IL-1beta	Gene	3553
10976648	576	578	AD	Disease	MESH:D000544
10976648	Positive_Correlation	MESH:D000544	12
10976648	Association	12	3553
10976648	Association	MESH:D000544	3552
10976648	Positive_Correlation	MESH:D000544	3553

